SEC 13F Intelligence

Penserra Capital Management LLC / HQL

Penserra Capital Management LLC’s Abrdn Life Sciences Investor Position

Does Penserra Capital Management LLC own Abrdn Life Sciences Investor (HQL)? Yes — 806.9K shares worth $13M (+0.15% of its 13F portfolio) as of Q1 2026, down from 875.1K shares the prior filed quarter.

Position Value
$13M
Q1 2026
Shares
806.9K
% of Portfolio
+0.15%
Quarters Held
7
currently held

Position History HQL

Reported value by quarter
Q3 ’24: $12MQ3 ’24Q4 ’24: $11MQ4 ’24Q1 ’25: $9MQ1 ’25Q2 ’25: $10MQ2 ’25Q3 ’25: $12MQ3 ’25Q4 ’25: $15MQ4 ’25Q1 ’26: $13MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026806.9K$13M+0.15%
Q4 2025875.1K$15M+0.17%
Q3 2025794.1K$12M+0.15%
Q2 2025769.7K$10M+0.14%
Q1 2025746.9K$9M+0.17%
Q4 2024827.6K$11M+0.20%
Q3 2024776.0K$12M+0.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Penserra Capital Management LLC’s full portfolio or all institutional holders of HQL.